Today: 19 May 2026
Browse Category

NASDAQ:ACLX 9 December 2025 - 25 February 2026

Arcellx stock jumps 78% on Gilead’s $7.8 billion buyout — deal terms, risks and next catalyst

Arcellx stock jumps 78% on Gilead’s $7.8 billion buyout — deal terms, risks and next catalyst

Arcellx shares jumped 77.6% to $113.84 after Gilead Sciences agreed to buy the company for $115 per share in cash plus a contingent value right tied to anito-cel sales. The deal came as U.S. stocks fell on new 15% global tariffs announced by President Trump. Gilead shares slipped 0.6%. Investors are watching the FDA’s Dec. 23, 2026 review deadline for anito-cel, a CAR-T therapy for multiple myeloma.
23 February 2026
··
Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Arcellx shares surged 78% to $113.92 after Gilead Sciences agreed to acquire the company for $115 per share in cash, plus a $5 contingent payout tied to anito-cel sales, valuing Arcellx at up to $7.8 billion. The companies expect to close the deal in Q2 2026. Trading volume in Arcellx topped 11 million shares by mid-morning. Gilead shares fell 0.5%.
23 February 2026
····
Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx shares closed at $72.08 on December 9, down 2.7% after surging 13.6% pre-market on positive Phase 2 data for its multiple myeloma therapy anito-cel at ASH 2025. The iMMagine-1 study showed a 96% overall response rate and no delayed neurotoxicities in 117 heavily pretreated patients. Analysts maintain a “Strong Buy” consensus and anticipate a 2026 commercial launch.
9 December 2025
··

Stock Market Today

  • Soybeans Edge Higher on US-China Trade Prospects and Crop Progress
    May 19, 2026, 10:49 AM EDT. Soybean futures rose by 1 to 2.5 cents on Tuesday morning, following a 19.75 to 36 cent gain on Monday amid renewed buying in new crop contracts. The USDA indicated 67% of U.S. soybeans were planted by May 17, outpacing the five-year average. U.S.-China trade talks boosted optimism, with China agreeing to purchase at least $17 billion annually of U.S. agricultural products from 2026 to 2028, supplementing earlier soybean commitments. Soybean export shipments last week declined 27.1% from the previous week but doubled year-over-year, led by China, Mexico, and Egypt. Nearby cash prices rose to $11.49 per bushel. Soymeal and soy oil futures also advanced, supporting overall gains in soy markets.

Latest articles

Generation Income Properties Up 46% After Heavy Volume

Generation Income Properties Up 46% After Heavy Volume

19 May 2026
Generation Income Properties shares surged 45.5% to $0.3549 in early Nasdaq trading Tuesday, with volume above 105 million shares. The spike followed insider-ownership filings after a board shakeup, not new earnings or property sales. The company reported a $2.13 million quarterly loss and warned of “substantial doubt” about its ability to continue as a going concern. Nasdaq has given it until August 4 to meet equity requirements.
Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

19 May 2026
Snowflake shares rose 6.3% to $174.62 in morning trading Tuesday, outperforming major U.S. index funds. BofA Securities raised its price target to $205, citing strong demand for Snowflake’s AI tools. The company reports fiscal first-quarter results after the U.S. market close on May 27. Trading volume reached 3.6 million shares, with a market value near $59.4 billion.
Agilysys Shares Rally After Strong Quarter; 2027 Guidance Catches Focus

Agilysys Shares Rally After Strong Quarter; 2027 Guidance Catches Focus

19 May 2026
Agilysys shares jumped 28% to $89.96 Tuesday after the company reported record fiscal fourth-quarter revenue of $82.9 million and projected 2027 revenue of $365 million to $370 million. Subscription revenue grew 30.2% for the year. Oppenheimer raised its price target to $100, while Needham kept a $120 target. Trading volume topped 555,000 shares, well above average.

Popular

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

18 May 2026
Intel shares rose 0.3% to $109.10 in early New York trading Monday after last week’s selloff, as analysts raised price targets and President Trump commented on the U.S. government’s 10% stake, now valued above $50 billion. First-quarter revenue climbed 7% to $13.6 billion, with Data Center and AI sales up 22%. The iShares Semiconductor ETF fell 0.9%. Intel’s server CPU market share dropped to 54.9% in Q1, according to UBS.
Go toTop